An observational study in Radiculopathy and Cervical Disk Disease, sponsored by Akdeniz University Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Akdeniz University Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 60 studies in Radiculopathy with a site in Turkey — 16 open to participants now, 19 under way, none of them phase 3. Radiculopathy · Turkey.
Among the 60 studies in Radiculopathy with a site in Turkey, this one is the 20th largest by enrollment of the 27 observational ones that give a count, is one of 7 that started in 2021, is one of 27 observational ones, and was the 60th registered.
486 studies on the registry are indexed under Radiculopathy; 145 are open to participants now.
Browse Radiculopathy studies →16 of the 60 studies in Radiculopathy with a site in Turkey are open now. Recruiting first, the newest first:
Ankara City Hospital Bilkent · Sites in Turkey
Marmara University · Sites in Turkey
Ages 18 mo+
Alİ Eman, MD · Sites in Turkey
Ages 18–55
Izmir City Hospital · Sites in Turkey
Ages 18–65
Necmettin Erbakan University · Sites in Turkey
Ages 18–70
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 80 Radiculopathy studies recruiting now, 23 (29%) set no upper age limit and 49 (61%) stop at 75 or younger; 3 take children under 18; 7 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
60 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 7 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 75 is below the median of 96 across 97 observational studies indexed under Radiculopathy.
Median enrollment 60 across the 33 interventional studies, 107 across the 27 observational. Of the 34 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 60 have an industry lead sponsor. The 10 most frequent:
Akdeniz University Hospital is the lead sponsor of 10 studies on the registry; 4 are open to participants now.
Akdeniz University Hospital has 1 study filed under Radiculopathy — fewer than ten, so there is no comparison to draw.
5 of the studies in Radiculopathy with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07776431Marmara UniversityElectrophysiological Predictors of Cervical DRG Pulsed Radiofrequency Outcomes | 2026-11 |
| NCT07823426Ankara City Hospital BilkentCervical Spinal Cord Signal Abnormalities in Patients With Cervical Radicular Pain | 2027-02-28 |
| NCT07799142Marmara UniversityFemoral Stretch Test in L2-L4 Lumbar Radiculopathy | 2027-03 |
| NCT07400068Mersin UniversityPLDD With or Without Transforaminal Epidural Steroid Injection in Lumbar Disc Herniation | 2027-04-01 |
| NCT07787741Alİ Eman, MDCervical Epidural Block in Chronic Neck Pain | 2027-10-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 60 studies in Radiculopathy with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Percutaneous Epidural Neuroplasty (PEN) is a minimally invasive treatment option used for the management of back and neck pain.
The investigators aimed to evaluate the effects of different saline concentrations (0.9%, 5%, 10%) used during the cervical PEN procedure on post-procedure NRS and NDI scores.
Epidural injections of corticosteroids and local anesthetics (LA) deliver high concentrations of therapeutic agents into the epidural space to inhibit inflammation and reduce nociceptive afferent signaling. The two most common approaches for cervical epidural steroid injections (ESI) are transforaminal (TFESI) and interlaminar (IESI) injections. . Cervical percutaneous epidural neuroplasty (PEN) was derived from lumbar PEN and is utilized as a treatment option for cervical disc herniation.
While different saline concentrations have been evaluated in caudal PEN and transforaminal injections, no study to date has specifically compared different saline concentrations in cervical PEN. In this study, cervical lysis was performed on participants with single-level, unilateral cervical disc herniation. Saline solutions of varying concentrations were administered during the procedure. Therefore, the investigators objective was to compare the impact of different saline concentrations (0.9%, 5%, and 10%) used during the cervical PEN procedure on the procedure's success by evaluating NRS and NDI scores.
Between October 2021 and January 2023, 75 consecutive patients diagnosed with single-level, unilateral cervical disc herniation at the Akdeniz University Algology Clinic were enrolled in the study. Participants. were divided into three groups of 25 individuals each, using a computer-based algorithm for randomization according to the saline concentration to be administered:
Patients diagnosed with unilateral cervical disc herniation and treated with cervical lysis
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
0.9% NaCl was used in this patient group.
5% NaCl was used in this patient group.
10% NaCl was used in this patient group.
Comparison of the effect of percutaneous cervical epidural neurolysis in the acute phase with baseline NRS scores
Participants provided a response regarding their pain score, as measured on an NRS scale ranging from 0 (best outcome) to 10 (worst outcome).
Time frame: 0-1 MOUNTH
Comparison of the effects of different salin concentrations used in cervical epidural neurolysis on NDI and NRS scores
Participants reported their pain scores at 1, 3, 6, and 12 months using an NRS scale ranging from 0 (best outcome) to 10 (worst outcome), and their disability scores using an NDI scale ranging from 0 (no disability) to 50 (complete disability)..
Time frame: 1-3-6-12 MOUNTH
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — Individual patient data will not be shared; statistical results of patient data will be shared.
Ran from Oct 2021 to primary completion in Jan 2023, 15 months.
Of 41 observational studies under Radiculopathy, half reached primary completion within 75 months of starting (the median), counting those still running; a quarter within 26 and three quarters within 95. This study's 15 months is below that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Akdeniz University Hospital